Q32 Bio (QTTB) Analyst & Key Data

Analyst Consensus

Buy6 analysts

Buy

Updated Sep 12, 2026

Total Analysts6

Buy

4

Hold

4

Ratings

Updated Sep 12, 2026

Overall Rating

A

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score3.0 / 5

ROA Score5.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$11.10

Median Target+204.77%

$33.83

Potential upside vs current price

DCF Value-16.99%

$9.21

Potential downside vs current price

Current Stock Price

$11.10

Median Target+204.77%

$33.83

Potential upside vs current price

DCF Value-16.99%

$9.21

Potential downside vs current price

Analyst Consensus

Buy6 analysts

Buy

Updated Sep 12, 2026

Total Analysts6

Buy

4

Hold

4

Ratings

Updated Sep 12, 2026

Overall Rating

A

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score3.0 / 5

ROA Score5.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$11.10

Median Target+204.77%

$33.83

Potential upside vs current price

DCF Value-16.99%

$9.21

Potential downside vs current price

Current Stock Price

$11.10

Median Target+204.77%

$33.83

Potential upside vs current price

DCF Value-16.99%

$9.21

Potential downside vs current price

Q32 Bio Inc.